Heart Attack News and Research

RSS

Increased incidence of Type 2 diabetes in children

Alarming increases of Type 2 diabetes in children are no closer to being managed successfully according to a study in The New England Journal of Medicine showing common diabetes-control medications failed to work in children.

28 Aug 2012

Major decline in early mortality for STEMI patients: French registries

Data from four French nationwide registries of STEMI (ST-elevation myocardial infarction) patients initiated five years apart and covering more than 15 years show that mortality rate decreased by 68% over this period, from 13.7% to 4.4%. Around one quarter of this mortality reduction could be attributed to a change in patient characteristics.

28 Aug 2012

Positive results from CardioKinetix’s Parachute device clinical trial on ischemic heart failure

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.

28 Aug 2012

ICU misdiagnosis alarmingly common in the acute care setting

Each year as many as 40,500 critically ill U.S. hospital patients die with an unknown medical condition that may have caused or contributed to their death, Johns Hopkins patient safety experts report in a recent study.

28 Aug 2012

Disruption of circadian rhythm can inhibit blood vessel growth in the body

Disruptions to the circadian rhythm can affect the growth of blood vessels in the body, thus causing illnesses such as diabetes, obesity, and cancer, according to a new study from Linköping University and Karolinska Institutet in Sweden.

28 Aug 2012

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.

28 Aug 2012

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

The state has eliminated a waiting list for a program that provides lifesaving medications to thousands of low-income, uninsured Georgians with HIV/AIDS more than two years after the list was first started. Established in July 2010, the wait list for Georgia's AIDS Drug Assistance Program rapidly ballooned to more than 1,600 -- at one time becoming the largest in the country. A spike in the need for the program was largely fueled by the economic downturn as people lost their jobs and health insurance.

28 Aug 2012

Insulin glargine retards progression of atherosclerosis in high-risk people

A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.

27 Aug 2012

Update on Merck's development programs for vorapaxar, ER niacin/laropirprant and anacetrapib

Merck today provided an update on the development programs for vorapaxar, extended release niacin/laropirprant (MK524A, Tredaptive) and anacetrapib in association with the European Society of Cardiology (ESC) meeting in Munich.

27 Aug 2012

IABP does not improve blood pressure symptoms in patients with cardiogenic shock

A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people.

27 Aug 2012

Renal denervation safe and effective in patients with treatment resistant hypertension

Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012.

27 Aug 2012

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.

27 Aug 2012

Parachute device improves outcomes in patients with ischemic heart failure

A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress 2012.

26 Aug 2012

Women with heart attack symptoms receive lower quality of care than men

A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.

23 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

22 Aug 2012

Highly sensitive troponin assay shortens heart attack diagnosis

An algorithm that incorporates high-sensitivity cardiac troponin could allow accurate rule-in and rule-out of patients with acute chest pain within 1 hour of presentation, a study shows.

21 Aug 2012

UCLA Medical Center receives platinum award for outstanding heart attack care

Ronald Reagan UCLA Medical Center has received an award for outstanding heart attack care from the American College of Cardiology Foundation called the NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2012.

21 Aug 2012

Third universal definition of myocardial infarction to be presented at ESC Congress 2012

A new definition of heart attack will be presented at the ESC Congress 2012. The third universal definition of myocardial infarction (MI) clarifies the controversial area of procedural related MI and will be the gold standard for diagnosis and clinical trial endpoints.

17 Aug 2012

U of U researchers receive NIH grant to study cellular and molecular causes of blood clots

University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.

15 Aug 2012

Heart Attack News and Research

Increased incidence of Type 2 diabetes in children

Major decline in early mortality for STEMI patients: French registries

Positive results from CardioKinetix’s Parachute device clinical trial on ischemic heart failure

ICU misdiagnosis alarmingly common in the acute care setting

Disruption of circadian rhythm can inhibit blood vessel growth in the body

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

Insulin glargine retards progression of atherosclerosis in high-risk people

Update on Merck's development programs for vorapaxar, ER niacin/laropirprant and anacetrapib

IABP does not improve blood pressure symptoms in patients with cardiogenic shock

Renal denervation safe and effective in patients with treatment resistant hypertension

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

Parachute device improves outcomes in patients with ischemic heart failure

Women with heart attack symptoms receive lower quality of care than men

FDA warns consumers about potential health risks of two natural dietary supplements

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

Highly sensitive troponin assay shortens heart attack diagnosis

UCLA Medical Center receives platinum award for outstanding heart attack care

Third universal definition of myocardial infarction to be presented at ESC Congress 2012

U of U researchers receive NIH grant to study cellular and molecular causes of blood clots

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News